Explore it now
28th Annual ESGO 2027 Congress
Discover it Now!
ENGOT coordinates and promotes gynaecological cancer clinical trials in Europe
Explore ENGOT
Explore ESGO’s Membership Benefits
Read More
ENITEC in a pan-European academic network of clinical and translational researchers in gynaecological oncology founded in 2012.
Our mission is to unite multidisciplinary experts on uterine cancer to promote high-impact translational research with a common goal to improve the health and well-being of women with uterine cancer.
We are an internationally recognised research network in uterine cancer, our discoveries lead to improved patient outcomes and set new benchmarks in clinical practice.
Researchers within the network have widely varying backgrounds, including clinical (gynaecology, pathology, radiology), molecular biologists and pharmacists to name a few.
All ENITEC members are encouraged to become an ESGO member.
Since ENITECs foundation, over 130 researchers from research groups all across Europe have become involved.
ENITEC organises an annual meeting at the ESGO Annual Congress where all ENITEC-associated researchers are invited to join. The network discusses updates about the ongoing collaborative studies and evaluates the proposal of new projects. New members are always welcome.
2011 Leuven, Belgium
2012 Bergen, Norway
2013 Barcelona, Spain
2014 Leiden, The Netherlands
2015 Copenhagen, Denmark
2016 Freiburg, Germany
2017 Lublin, Poland
2018 Amsterdam, The Netherlands
2019 Liverpool, United Kingdom
2020 Virtual Meeting
2021 Virtual Meeting
2022 Porto, Portugal
2023 Ljubljana, Slovenia
2024 Barcelona, Spain
2025 Rome, Italy
2026 Copenhagen, Denmark
ENITEC is an open European Research Network that welcomes new memberships from multidisciplinary experts on uterine cancer which shared the mission to promote high-impact translational research in order to improve the health and well-being of women with uterine cancer.
Joining the ENITEC consortium offers numerous benefits for professionals dedicated to advancing uterine cancer research and care. As part of a dynamic and collaborative European Research Network, members gain access to a broad, multidisciplinary community of experts committed to high-impact translational research. This collaboration fosters opportunities for joint projects, shared resources, and innovative approaches to improving diagnostics, treatment, and patient outcomes. One of the key highlights is the annual ENITEC meeting, where all members come together for fruitful discussions, knowledge exchange, and strategic planning to drive forward the consortium’s mission. Additionally, members can actively contribute to shaping the future of uterine cancer research, influence clinical practice guidelines, and engage in meaningful collaborations, all with the shared goal of enhancing the health and well-being of women affected by uterine cancer.
To join, simply contact us: enitec@enitec.eu.
Vit Weinberger (ENITEC President)
Head of the Department
Department of Obstetrics and Gynecology
University Hospital Brno & Faculty of Medicine
Masaryk University
Brno, Czech Republic
Weinberger.Vit@fnbrno.cz
Eva Colas
Co-Director
Group of Biomedical Research in Gynecology
Vall d´Hebron Institut de Recerca (VHIR)
Barcelona, Spain
eva.colas@vhir.org
Camilla Krakstad
Professor, Group Leader
Bergen Gyn Cancer Research Group
Department of Clinical Science, University of Bergen
Section for Gynecologic Oncology, Haukeland University Hospital
Bergen, Norway
camilla.krakstad@uib.no
Hanny (JMA) Pijnenborg
Professor & Research Group Leader
Radboud University Medical Center
Nijmegen, the Netherlands
hanny.ma.pijnenborg@radboudumc.nl
Marcin Bobiński
Chair (Acting)
Independent Laboratory of Translational Medicine
Chair of Medical Genetics
Medical University of Lublin
Lublin, Poland
marcin.bobinski@umlub.pl
10.09.2026 - 25.09.2026 Valencia Spain Level: Advanced
Learn more
14.12.2026 - 15.12.2026 Milan, Italy Level: Advanced
17.12.2026 (Theory session online) & 14.1. 2027 (Video session online) Level: Advanced